Gene · 6760
SS18: SS18 subunit of BAF chromatin remodeling complex
12 sourcesgene-search-2026-11-11-0.2.0
Cite this record
ConductScience Library. SS18: SS18 subunit of BAF chromatin remodeling complex. Genes, record 6760. Release gene-search-2026-11-11-0.2.0, 11 Nov 2026. https://conductscience.org/library/genes/6760
On this page
Gene
Proteins1
Reviewed human proteins whose Swiss-Prot entry states the gene.
| UniProt entry | Protein | Length | Structures | Gene stated in |
|---|---|---|---|---|
| Q15532 | Protein SSXT | 418 | 1 | Ensembl, GeneID, HGNC |
Source UniProt
Patents17
Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.
| Publication | Published | SEQ ID NO | Protein | Source |
|---|---|---|---|---|
| JP 2026004568 A | 2026-01-14 | 66172 | Q15532 | Espacenet |
| EP 4650780 A2 | 2025-11-19 | 13893 | Q15532 | Espacenet |
| JP 2025164846 A | 2025-10-30 | 18 | Q15532 | Espacenet |
| JP 2025517970 A | 2025-06-12 | 13893 | Q15532 | Espacenet |
| US 11446398 B2 | 2022-09-20 | 85887 | Q15532 | Espacenet |
| WO 2022138944 A | 2022-06-30 | 34 | Q15532 | Espacenet |
| JP 2022524081 A | 2022-04-27 | 188858 | Q15532 | Espacenet |
| US 11078247 B2 | 2021-08-03 | 11002 | Q15532 | Espacenet |
| WO 2021132592 A | 2021-07-01 | 71 | Q15532 | Espacenet |
| JP 2019054813 A | 2019-04-11 | 246607 | Q15532 | Espacenet |
1 to 10 of 17
See all 17 patentsDrugs0
Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.
None in this release.
Trials0
Trials of those drugs. A trial joins the gene only through a drug that acts on it.
None in this release.
NIH grants759
NIH grants whose papers are about the gene, through NIH's grant-paper links.
| Grant | Title | SS18 papers | Newest fiscal year |
|---|---|---|---|
| P30CA008748 | Cancer Center Support Grant | 41 | 2025 |
| P50CA217694 | SPORE in Soft Tissue Sarcoma | 16 | 2025 |
| P30CA016672 | Cancer Center Support Grant | 9 | 2025 |
| R01CA163915 | ATP-Dependent Chromatin Remodeling in Human Malignancy | 9 | 2025 |
| P30CA042014 | Cancer Center Support Grant | 8 | 2025 |
| P30CA068485 | Cancer Center Support Grant | 8 | 2025 |
| P30CA021765 | Cancer Center Support Grant (CCSG) | 6 | 2025 |
| P30EY008126 | Core Grant in Vision Research | 5 | 2025 |
| P01CA066996 | Development of Novel Therapeutic Strategies in Human Leukemias | 4 | 2025 |
| P30DK058404 | Molecular and Cellular Basis for Digestive Diseases | 4 | 2025 |
1 to 10 of 759Source NIH's project files
See all 759 nih grantsPapers1,411
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Diagnostic Utility of SS18-SSX Fusion-Specific and SSX C-Terminus Antibodies in Synovial Sarcoma: Validation in a Large Indian Tertiary Care Cohort. | Appl Immunohistochem Mol Morphol | 2026 | 42820281 | PubTator, text mining | PubMed |
| A Rare Case of Poorly Differentiated Synovial Sarcoma of the Superficial Neck: Diagnostic Approach in a Fine-Needle Aspiration Specimen. | Diagn Cytopathol | 2026 | 42808294 | PubTator, text mining | PubMed |
| When rare becomes real: diagnostic challenges and use of a multidisciplinary team-based decision in primary pulmonary synovial sarcoma. | BMJ Case Rep | 2026 | 42608070 | PubTator, text mining | PubMed |
| Primary pulmonary artery synovial sarcoma: a case report. | AME Case Rep | 2026 | 42592483 | PubTator, text mining | PubMed |
| Primary ovarian synovial sarcoma in an adolescent mimicking a germ cell tumor: A case report and diagnostic challenge. | Gynecol Oncol Rep | 2026 | 42555456 | PubTator, text mining | PubMed |
| [Clinical analysis of 9 children of B-cell acute lymphoblastic leukemia with MEF2D gene rearrangement]. | Zhonghua Er Ke Za Zhi | 2026 | 42527140 | PubTator, text mining | PubMed |
| Plantar synovial sarcoma mimicking a vascular malformation in a child: a clinicopathologic case report. | Int Cancer Conf J | 2026 | 42491187 | PubTator, text mining | PubMed |
| Driver vs. passenger: Primary resistance to larotrectinib in synovial sarcoma harboring concurrent SS18 rearrangement and PDE3A-NTRK2 fusion. | Tumori | 2026 | 42376758 | PubTator, text mining | PubMed |
| Primary renal synovial sarcoma: a clinicopathological study of 23 cases highlighting the diagnostic value of SS18-SSX, TLE1, and INI1 immunohistochemistry panel. | Virchows Arch | 2026 | 42371005 | PubTator, text mining | PubMed |
| SMARCB1-Deficient Malignant Orbital Neoplasm with Features Overlapping Myxoid Epithelioid Sarcoma: A Diagnostic Challenge. | Head Neck Pathol | 2026 | 42340513 | PubTator, text mining | PubMed |
1 to 10 of 1,411
See all 1,411 papersSources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this gene from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/genes/v1/6760
GET https://conductscience.org/api/genes/v1/6760/patents